Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: Psilocybin for Methamphetamine Addiction [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase study evaluating psilocybin for methamphetamine use disorder and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Kevin Murnane | Conditions: Methamphetamine Use Disorder | EARLY_Phase 1 | Status: RECRUITING